-
1
-
-
69449092791
-
Managing toxicities associated with colorectal cancer chemotherapy and targeted therapy: A new guide for nurses
-
Grenon NN and Chan J: Managing toxicities associated with colorectal cancer chemotherapy and targeted therapy: a new guide for nurses. Clin J Oncol Nurs 13: 285-296, 2009.
-
(2009)
Clin J Oncol Nurs
, vol.13
, pp. 285-296
-
-
Grenon, N.N.1
Chan, J.2
-
2
-
-
14544294545
-
Bioactive microbial metabolites
-
Tokyo
-
Berdy J: Bioactive microbial metabolites. J Antibiot (Tokyo) 58: 1-26, 2005.
-
(2005)
J Antibiot
, vol.58
, pp. 1-26
-
-
Berdy, J.1
-
3
-
-
73449131956
-
Antitumor compounds from marine actinomycetes
-
Olano C, Mendez C and Salas JA: Antitumor compounds from marine actinomycetes. Mar Drugs 7: 210-248, 2009.
-
(2009)
Mar Drugs
, vol.7
, pp. 210-248
-
-
Olano, C.1
Mendez, C.2
Salas, J.A.3
-
4
-
-
34247109045
-
Natural products as sources of new drugs over the last 25 years
-
Newman DJ and Cragg GM: Natural products as sources of new drugs over the last 25 years. J Nat Prod 70: 461-477, 2007.
-
(2007)
J Nat Prod
, vol.70
, pp. 461-477
-
-
Newman, D.J.1
Cragg, G.M.2
-
5
-
-
65349093437
-
Antitumor compounds from actinomycetes: From gene clusters to new derivatives by combinatorial biosynthesis
-
Olano C, Mendez C and Salas JA: Antitumor compounds from actinomycetes: from gene clusters to new derivatives by combinatorial biosynthesis. Nat Prod Rep 26: 628-660, 2009.
-
(2009)
Nat Prod Rep
, vol.26
, pp. 628-660
-
-
Olano, C.1
Mendez, C.2
Salas, J.A.3
-
7
-
-
77957870880
-
Actinomycetes and fungi isolated from Maliau Basin, Sabah and the screening for novel secondary metabolites against eukaryotic signal transduction and mycobacterium
-
Voo CLY, Lai NS, Kibat C, et al: Actinomycetes and fungi isolated from Maliau Basin, Sabah and the screening for novel secondary metabolites against eukaryotic signal transduction and mycobacterium. J Trop Biol Conserv 3: 11-56, 2007.
-
(2007)
J Trop Biol Conserv
, vol.3
, pp. 11-56
-
-
Voo, C.L.Y.1
Lai, N.S.2
Kibat, C.3
-
8
-
-
23944526062
-
Activation of AKT kinases in cancer: Implications for therapeutic targeting
-
DOI 10.1016/S0065-230X(05)94002-5, PII S0065230X05940025
-
Bellacosa A, Kumar CC, Di Cristofano A and Testa JR: Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res 94: 29-86, 2005. (Pubitemid 41202364)
-
(2005)
Advances in Cancer Research
, vol.94
, Issue.1 SUPPL.
, pp. 29-86
-
-
Bellacosa, A.1
Kumar, C.C.2
Cristofano, A.D.3
Testa, J.R.4
-
9
-
-
34248583886
-
MAP kinase signalling pathways in cancer
-
DOI 10.1038/sj.onc.1210421, PII 1210421
-
Dhillon AS, Hagan S, Rath O and Kolch W: MAP kinase signalling pathways in cancer. Oncogene 26: 3279-3290, 2007. (Pubitemid 46763021)
-
(2007)
Oncogene
, vol.26
, Issue.22
, pp. 3279-3290
-
-
Dhillon, A.S.1
Hagan, S.2
Rath, O.3
Kolch, W.4
-
10
-
-
62549121734
-
Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells
-
Borley AC, Hiscox S, Gee J, et al: Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells. Breast Cancer Res 10: R103, 2008.
-
(2008)
Breast Cancer Res
, vol.10
-
-
Borley, A.C.1
Hiscox, S.2
Gee, J.3
-
11
-
-
23844504520
-
Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis
-
Koblinski JE, Kaplan-Singer BR, van Osdol SJ, et al: Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis. Cancer Res 65: 7370-7377, 2005.
-
(2005)
Cancer Res
, vol.65
, pp. 7370-7377
-
-
Koblinski, J.E.1
Kaplan-Singer, B.R.2
Van Osdol, S.J.3
-
12
-
-
0021714105
-
Tumor invasion and metastases: Role of the basement membrane. Warner-Lambert Parke-Davis Award lecture
-
Liotta LA: Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. Am J Pathol 117: 339-348, 1984.
-
(1984)
Am J Pathol
, vol.117
, pp. 339-348
-
-
Liotta, L.A.1
-
13
-
-
0031953809
-
Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells
-
Ree AH, Bjornland K, Brunner N, et al: Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells. Clin Exp Metastasis 16: 205-215, 1998.
-
(1998)
Clin Exp Metastasis
, vol.16
, pp. 205-215
-
-
Ree, A.H.1
Bjornland, K.2
Brunner, N.3
-
14
-
-
33751358425
-
Green tea polyphenol epigallocatechin-3-gallate suppresses rat hepatic stellate cell invasion by inhibition of MMP-2 expression and its activation
-
Zhen MC, Huang XH, Wang Q, et al: Green tea polyphenol epigallocatechin-3-gallate suppresses rat hepatic stellate cell invasion by inhibition of MMP-2 expression and its activation. Acta Pharmacol Sin 27: 1600-1607, 2006.
-
(2006)
Acta Pharmacol Sin
, vol.27
, pp. 1600-1607
-
-
Zhen, M.C.1
Huang, X.H.2
Wang, Q.3
-
15
-
-
0037195142
-
Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells
-
Kato-Stankiewicz J, Hakimi I, Zhi G, et al: Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells. Proc Natl Acad Sci USA 99: 14398-14403, 2002.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 14398-14403
-
-
Kato-Stankiewicz, J.1
Hakimi, I.2
Zhi, G.3
-
16
-
-
0022499236
-
Basement membrane complexes with biological activity
-
Kleinman HK, McGarvey ML, Hassell JR, et al: Basement membrane complexes with biological activity. Biochemistry 25: 312-318, 1986.
-
(1986)
Biochemistry
, vol.25
, pp. 312-318
-
-
Kleinman, H.K.1
McGarvey, M.L.2
Hassell, J.R.3
-
18
-
-
0026762677
-
Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment
-
Melchiori A, Albini A, Ray JM and Stetler-Stevenson WG: Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment. Cancer Res 52: 2353-2356, 1992.
-
(1992)
Cancer Res
, vol.52
, pp. 2353-2356
-
-
Melchiori, A.1
Albini, A.2
Ray, J.M.3
Stetler-Stevenson, W.G.4
-
19
-
-
0034486945
-
Imaging proteolysis by living human breast cancer cells
-
Sameni M, Moin K and Sloane BF: Imaging proteolysis by living human breast cancer cells. Neoplasia 2: 496-504, 2000. (Pubitemid 32098684)
-
(2000)
Neoplasia
, vol.2
, Issue.6
, pp. 496-504
-
-
Sameni, M.1
Moin, K.2
Sloane, B.F.3
-
20
-
-
0036585606
-
Retinoblastoma function is a better indicator of cellular phenotype in cultured breast adenocarcinoma cells than retinoblastoma expression
-
Botos J, Smith R III and Kochevar DT: Retinoblastoma function is a better indicator of cellular phenotype in cultured breast adenocarcinoma cells than retinoblastoma expression. Exp Biol Med 227: 354-362, 2002.
-
(2002)
Exp Biol Med
, vol.227
, pp. 354-362
-
-
Botos, J.1
Smith III, R.2
Kochevar, D.T.3
-
21
-
-
0029033861
-
The retinoblastoma protein and cell cycle control
-
Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
-
(1995)
Cell
, vol.81
, pp. 323-330
-
-
Weinberg, R.A.1
-
22
-
-
0025905183
-
The E2F transcription factor is a cellular target for the RB protein
-
Chellappan SP, Hiebert S, Mudryj M, Horowitz JM and Nevins JR: The E2F transcription factor is a cellular target for the RB protein. Cell 65: 1053-1061, 1991. (Pubitemid 121001693)
-
(1991)
Cell
, vol.65
, Issue.6
, pp. 1053-1061
-
-
Chellappan, S.P.1
Hiebert, S.2
Mudryj, M.3
Horowitz, J.M.4
Nevins, J.R.5
-
23
-
-
0029028354
-
Interaction between the retinoblastoma protein and the oncoprotein MDM2
-
Xiao ZX, Chen J, Levine AJ, et al: Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375: 694-698, 1995.
-
(1995)
Nature
, vol.375
, pp. 694-698
-
-
Xiao, Z.X.1
Chen, J.2
Levine, A.J.3
-
24
-
-
0027429964
-
A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle
-
Welch PJ and Wang JY: A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75: 779-790, 1993.
-
(1993)
Cell
, vol.75
, pp. 779-790
-
-
Welch, P.J.1
Wang, J.Y.2
-
25
-
-
0029924241
-
Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites
-
Knudsen ES and Wang JY: Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J Biol Chem 271: 8313-8320, 1996.
-
(1996)
J Biol Chem
, vol.271
, pp. 8313-8320
-
-
Knudsen, E.S.1
Wang, J.Y.2
-
26
-
-
0030849455
-
Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation
-
Knudsen ES and Wang JY: Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol 17: 5771-5783, 1997.
-
(1997)
Mol Cell Biol
, vol.17
, pp. 5771-5783
-
-
Knudsen, E.S.1
Wang, J.Y.2
-
27
-
-
0032146274
-
The regulation of E2F by pRB-family proteins
-
Dyson N: The regulation of E2F by pRB-family proteins. Genes Dev 12: 2245-2262, 1998.
-
(1998)
Genes Dev
, vol.12
, pp. 2245-2262
-
-
Dyson, N.1
-
28
-
-
0031019197
-
Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation
-
Connell-Crowley L, Harper JW and Goodrich DW: Cyclin D1/ Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol Cell 8: 287-301, 1997. (Pubitemid 27097944)
-
(1997)
Molecular Biology of the Cell
, vol.8
, Issue.2
, pp. 287-301
-
-
Connell-Crowley, L.1
Harper, J.W.2
Goodrich, D.W.3
-
29
-
-
28944437358
-
Structure of the Rb C-terminal domain bound to E2F1-DP1: A mechanism for phosphorylation-induced E2F release
-
DOI 10.1016/j.cell.2005.09.044, PII S0092867405012316
-
Rubin SM, Gall AL, Zheng N and Pavletich NP: Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell 123: 1093-1106, 2005. (Pubitemid 41785423)
-
(2005)
Cell
, vol.123
, Issue.6
, pp. 1093-1106
-
-
Rubin, S.M.1
Gall, A.-L.2
Zheng, N.3
Pavletich, N.P.4
-
30
-
-
0035095973
-
Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks
-
DOI 10.1016/S0304-419X(01)00019-1, PII S0304419X01000191
-
Adams PD: Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks. Biochim Biophys Acta 1471: M123-M133, 2001. (Pubitemid 32206688)
-
(2001)
Biochimica et Biophysica Acta - Reviews on Cancer
, vol.1471
, Issue.3
-
-
Adams, P.D.1
-
31
-
-
32244445684
-
Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3: Differential involvement in the distinct mitogenic modes of thyroid epithelial cells
-
Paternot S, Arsenijevic T, Coulonval K, Bockstaele L, Dumont JE and Roger PP: Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3: differential involvement in the distinct mitogenic modes of thyroid epithelial cells. Cell Cycle 5: 61-70, 2006.
-
(2006)
Cell Cycle
, vol.5
, pp. 61-70
-
-
Paternot, S.1
Arsenijevic, T.2
Coulonval, K.3
Bockstaele, L.4
Dumont, J.E.5
Roger, P.P.6
-
32
-
-
0030918714
-
1/S cyclin-dependent kinases
-
DOI 10.1074/jbc.272.19.12738
-
Zarkowska T and Mittnacht S: Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem 272: 12738-12746, 1997. (Pubitemid 27203373)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.19
, pp. 12738-12746
-
-
Zarkowska, T.1
Mittnacht, S.2
-
33
-
-
0033515543
-
Discovery of a regulatory motif that controls the exposure of specific upstream cyclin-dependent kinase sites that determine both conformation and growth suppressing activity of pRb
-
Driscoll B, T'Ang A, Hu YH, et al: Discovery of a regulatory motif that controls the exposure of specific upstream cyclin-dependent kinase sites that determine both conformation and growth suppressing activity of pRb. J Biol Chem 274: 9463-9471, 1999.
-
(1999)
J Biol Chem
, vol.274
, pp. 9463-9471
-
-
Driscoll, B.1
T'Ang, A.2
Hu, Y.H.3
-
34
-
-
0031844197
-
Defining the minimal portion of the retinoblastoma protein that serves as an efficient substrate for cdk4 kinase/cyclin D1 complex
-
DOI 10.1093/carcin/19.5.765
-
Pan W, Sun T, Hoess R and Grafstrom R: Defining the minimal portion of the retinoblastoma protein that serves as an efficient substrate for cdk4 kinase/cyclin D1 complex. Carcinogenesis 19: 765-769, 1998. (Pubitemid 28376765)
-
(1998)
Carcinogenesis
, vol.19
, Issue.5
, pp. 765-769
-
-
Pan, W.1
Sun, T.2
Hoess, R.3
Grafstrom, R.4
-
35
-
-
18244402890
-
Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro
-
DOI 10.1093/jb/mvi050
-
Takaki T, Fukasawa K, Suzuki-Takahashi I, et al: Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro. J Biochem 137: 381-386, 2005. (Pubitemid 40628445)
-
(2005)
Journal of Biochemistry
, vol.137
, Issue.3
, pp. 381-386
-
-
Takaki, T.1
Fukasawa, K.2
Suzuki-Takahashi, I.3
Semba, K.4
Kitagawa, M.5
Taya, Y.6
Hirai, H.7
-
36
-
-
0033578816
-
Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1
-
DOI 10.1016/S0092-8674(00)81519-6
-
Harbour JW, Luo RX, Dei Santi A, Postigo AA and Dean DC: Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98: 859-869, 1999. (Pubitemid 29446902)
-
(1999)
Cell
, vol.98
, Issue.6
, pp. 859-869
-
-
Harbour, J.W.1
Luo, R.X.2
Dei Santi, A.3
Postigo, A.A.4
Dean, D.C.5
-
37
-
-
0031951182
-
Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
-
Lundberg AS and Weinberg RA: Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18: 753-761, 1998.
-
(1998)
Mol Cell Biol
, vol.18
, pp. 753-761
-
-
Lundberg, A.S.1
Weinberg, R.A.2
-
38
-
-
0034948814
-
1 cyclin-dependent kinase complexes in vivo
-
DOI 10.1128/MCB.21.14.4773-4784.2001
-
Ezhevsky SA, Ho A, Becker-Hapak M, Davis PK and Dowdy SF: Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cell Biol 21: 4773-4784, 2001. (Pubitemid 32588257)
-
(2001)
Molecular and Cellular Biology
, vol.21
, Issue.14
, pp. 4773-4784
-
-
Ezhevsky, S.A.1
Ho, A.2
Becker-Hapak, M.3
Davis, P.K.4
Dowdy, S.F.5
-
39
-
-
34249066085
-
PCNA, the maestro of the replication fork
-
Moldovan GL, Pfander B and Jentsch S: PCNA, the maestro of the replication fork. Cell 129: 665-679, 2007.
-
(2007)
Cell
, vol.129
, pp. 665-679
-
-
Moldovan, G.L.1
Pfander, B.2
Jentsch, S.3
-
40
-
-
0041885325
-
Proliferating cell nuclear antigen (PCNA): A dancer with many partners
-
DOI 10.1242/jcs.00653
-
Maga G and Hubscher U: Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci 116: 3051-3060, 2003. (Pubitemid 37038954)
-
(2003)
Journal of Cell Science
, vol.116
, Issue.15
, pp. 3051-3060
-
-
Maga, G.1
Hubscher, U.2
-
41
-
-
0028783413
-
Myt1: A membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15
-
Mueller PR, Coleman TR, Kumagai A and Dunphy WG: Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science 270: 86-90, 1995.
-
(1995)
Science
, vol.270
, pp. 86-90
-
-
Mueller, P.R.1
Coleman, T.R.2
Kumagai, A.3
Dunphy, W.G.4
-
42
-
-
0026616796
-
Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase
-
Parker LL and Piwnica-Worms H: Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science 257: 1955-1957, 1992.
-
(1992)
Science
, vol.257
, pp. 1955-1957
-
-
Parker, L.L.1
Piwnica-Worms, H.2
-
43
-
-
65249132385
-
Fine tuning the cell cycle: Activation of the Cdk1 inhibitory phosphorylation pathway during mitotic exit
-
Potapova TA, Daum JR, Byrd KS and Gorbsky GJ: Fine tuning the cell cycle: activation of the Cdk1 inhibitory phosphorylation pathway during mitotic exit. Mol Biol Cell 20: 1737-1748, 2009.
-
(2009)
Mol Biol Cell
, vol.20
, pp. 1737-1748
-
-
Potapova, T.A.1
Daum, J.R.2
Byrd, K.S.3
Gorbsky, G.J.4
-
44
-
-
0035575533
-
Triggering the all-or-nothing switch into mitosis
-
O'Farrell PH: Triggering the all-or-nothing switch into mitosis. Trends Cell Biol 11: 512-519, 2001.
-
(2001)
Trends Cell Biol
, vol.11
, pp. 512-519
-
-
O'Farrell, P.H.1
-
45
-
-
0032986443
-
Butyrate augments interferon-alpha-induced S phase accumulation and persistent tyrosine phosphorylation of cdc2 in K562 cells
-
DOI 10.1038/sj.bjc.6690163
-
Miyachi T, Adachi M, Hinoda Y and Imai K: Butyrate augments interferon-alpha-induced S phase accumulation and persistent tyrosine phosphorylation of cdc2 in K562 cells. Br J Cancer 79: 1018-1024, 1999. (Pubitemid 29087869)
-
(1999)
British Journal of Cancer
, vol.79
, Issue.7-8
, pp. 1018-1024
-
-
Miyachi, T.1
Adachi, M.2
Hinoda, Y.3
Imai, K.4
-
46
-
-
27744485649
-
Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells
-
Tyagi A, Singh RP, Agarwal C, Siriwardana S, Sclafani RA and Agarwal R: Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis 26: 1978-1987, 2005.
-
(2005)
Carcinogenesis
, vol.26
, pp. 1978-1987
-
-
Tyagi, A.1
Singh, R.P.2
Agarwal, C.3
Siriwardana, S.4
Sclafani, R.A.5
Agarwal, R.6
-
47
-
-
0020601626
-
Loss of basement membrane components by invasive tumors but not by their benign counterparts
-
Barsky SH, Siegal GP, Jannotta F and Liotta LA: Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 49: 140-147, 1983. (Pubitemid 13039938)
-
(1983)
Laboratory Investigation
, vol.49
, Issue.2
, pp. 140-147
-
-
Barsky, S.H.1
Siegal, G.P.2
Jannotta, F.3
Liotta, L.A.4
-
48
-
-
0023797139
-
Type IV collagen immunoreactivity in colorectal cancer. Prognostic value of basement membrane deposition
-
Havenith MG, Arends JW, Simon R, Volovics A, Wiggers T and Bosman FT: Type IV collagen immunoreactivity in colorectal cancer. Prognostic value of basement membrane deposition. Cancer 62: 2207-2211, 1988.
-
(1988)
Cancer
, vol.62
, pp. 2207-2211
-
-
Havenith, M.G.1
Arends, J.W.2
Simon, R.3
Volovics, A.4
Wiggers, T.5
Bosman, F.T.6
-
49
-
-
33644545381
-
Tumour microenvironment - Opinion: Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
-
Overall CM and Kleifeld O: Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6: 227-239, 2006.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 227-239
-
-
Overall, C.M.1
Kleifeld, O.2
-
50
-
-
33947419786
-
Study of matrix metalloproteinases and their inhibitors in breast cancer
-
Vizoso FJ, Gonzalez LO, Corte MD, et al: Study of matrix metalloproteinases and their inhibitors in breast cancer. Br J Cancer 96: 903-911, 2007.
-
(2007)
Br J Cancer
, vol.96
, pp. 903-911
-
-
Vizoso, F.J.1
Gonzalez, L.O.2
Corte, M.D.3
-
51
-
-
0037805549
-
Basement membranes: Structure, assembly and role in tumour angiogenesis
-
Kalluri R: Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3: 422-433, 2003.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 422-433
-
-
Kalluri, R.1
-
52
-
-
0031297456
-
Control of matrix metalloproteinase activity in cancer
-
Jones JL and Walker RA: Control of matrix metalloproteinase activity in cancer. J Pathol 183: 377-379, 1997.
-
(1997)
J Pathol
, vol.183
, pp. 377-379
-
-
Jones, J.L.1
Walker, R.A.2
-
53
-
-
0032904304
-
Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis
-
Zeng ZS, Cohen AM and Guillem JG: Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis 20: 749-755, 1999.
-
(1999)
Carcinogenesis
, vol.20
, pp. 749-755
-
-
Zeng, Z.S.1
Cohen, A.M.2
Guillem, J.G.3
-
54
-
-
0035937389
-
Decrease of breast cancer cell invasiveness by sodium phenylacetate (NaPa) is associated with an increased expression of adhesive molecules
-
Vasse M, Thibout D, Paysant J, Legrand E, Soria C and Crepin M: Decrease of breast cancer cell invasiveness by sodium phenylacetate (NaPa) is associated with an increased expression of adhesive molecules. Br J Cancer 84: 802-807, 2001.
-
(2001)
Br J Cancer
, vol.84
, pp. 802-807
-
-
Vasse, M.1
Thibout, D.2
Paysant, J.3
Legrand, E.4
Soria, C.5
Crepin, M.6
|